NorthWest Healthcare Properties Real Estate Investment Trust - NWHUF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $14.44
  • Forecasted Upside: 83.22 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$7.88
▲ +0.23 (3.01%)

This chart shows the closing price for NWHUF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New NorthWest Healthcare Properties Real Estate Investment Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NWHUF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NWHUF

Analyst Price Target is $14.44
▲ +83.22% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for NorthWest Healthcare Properties Real Estate Investment Trust in the last 3 months. The average price target is $14.44, with a high forecast of $15.50 and a low forecast of $13.50. The average price target represents a 83.22% upside from the last price of $7.88.

This chart shows the closing price for NWHUF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 contributing investment analysts is to buy stock in NorthWest Healthcare Properties Real Estate Investment Trust. This rating has held steady since July 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/7/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/6/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/4/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/1/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/30/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/29/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/26/2022ScotiabankInitiated CoverageOutperformC$15.75 ➝ C$15.50
7/20/2022National Bank FinancialLower TargetC$15.00 ➝ C$13.50
7/4/2022BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$13.75
3/17/2022Royal Bank of CanadaBoost TargetC$14.50 ➝ C$15.00
3/17/2022BMO Capital MarketsBoost TargetC$14.50 ➝ C$15.70
11/23/2021Royal Bank of CanadaBoost TargetSector PerformC$14.00 ➝ C$14.50
11/17/2021National Bank FinancialBoost TargetSector PerformC$14.00 ➝ C$14.50
6/21/2021BMO Capital MarketsBoost TargetMarket PerformC$13.75 ➝ C$14.50
5/18/2021ScotiabankBoost TargetOutperformC$14.00 ➝ C$14.50
5/17/2021BMO Capital MarketsBoost TargetMarket PerformC$13.25 ➝ C$13.75
3/17/2021Royal Bank of CanadaBoost TargetSector Perform$13.00 ➝ $14.00
3/16/2021ScotiabankBoost TargetOutperform$13.50 ➝ $14.00
11/18/2020Royal Bank of CanadaBoost TargetSector Perform$12.00 ➝ $13.00
11/17/2020ScotiabankBoost TargetOutperform$12.75 ➝ $13.50
8/31/2020BMO Capital MarketsBoost TargetMarket Perform$11.50 ➝ $13.25
8/26/2020ScotiabankBoost TargetOutperform$12.00 ➝ $12.75
8/25/2020CIBCBoost Target$11.25 ➝ $11.75
5/20/2020ScotiabankLower TargetOutperform$13.00 ➝ $12.00
5/19/2020CIBCLower TargetNeutral$12.25 ➝ $11.25
2/10/2020ScotiabankUpgradeBuy$14.00
2/10/2020CIBCReiterated RatingHold$13.00
2/9/2020Royal Bank of CanadaReiterated RatingHold$13.00
12/23/2019Echelon Wealth PartnersReiterated RatingBuy$13.00
11/21/2019Echelon Wealth PartnersReiterated RatingBuy$13.00
8/9/2019Echelon Wealth PartnersReiterated RatingBuy
7/31/2019Echelon Wealth PartnersReiterated RatingBuy
(Data available from 9/29/2017 forward)

News Sentiment Rating

0.98 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/3/2022
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/2/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/2/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/1/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/31/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/30/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/29/2022

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
NorthWest Healthcare Properties Real Estate Investment Trust logo
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at September 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 190 income-producing properties and 15.4 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages over 200 professionals across nine offices in 5 countries to serve as a long-term real estate partner to leading healthcare operators.
Read More

Today's Range

Now: $7.88
Low: $7.87
High: $7.88

50 Day Range

MA: $9.67
Low: $7.69
High: $10.42

52 Week Range

Now: $7.88
Low: $7.69
High: $12.16

Volume

1,158 shs

Average Volume

4,938 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of NorthWest Healthcare Properties Real Estate Investment Trust?

The following sell-side analysts have issued reports on NorthWest Healthcare Properties Real Estate Investment Trust in the last year: BMO Capital Markets, National Bank Financial, Royal Bank of Canada, and Scotiabank.
View the latest analyst ratings for NWHUF.

What is the current price target for NorthWest Healthcare Properties Real Estate Investment Trust?

4 Wall Street analysts have set twelve-month price targets for NorthWest Healthcare Properties Real Estate Investment Trust in the last year. Their average twelve-month price target is $14.44, suggesting a possible upside of 83.2%. Scotiabank has the highest price target set, predicting NWHUF will reach $15.50 in the next twelve months. National Bank Financial has the lowest price target set, forecasting a price of $13.50 for NorthWest Healthcare Properties Real Estate Investment Trust in the next year.
View the latest price targets for NWHUF.

What is the current consensus analyst rating for NorthWest Healthcare Properties Real Estate Investment Trust?

NorthWest Healthcare Properties Real Estate Investment Trust currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NWHUF will outperform the market and that investors should add to their positions of NorthWest Healthcare Properties Real Estate Investment Trust.
View the latest ratings for NWHUF.

What other companies compete with NorthWest Healthcare Properties Real Estate Investment Trust?

How do I contact NorthWest Healthcare Properties Real Estate Investment Trust's investor relations team?

NorthWest Healthcare Properties Real Estate Investment Trust's physical mailing address is 180 Dundas Street West, Toronto, ON M5G. The company's listed phone number is (416) 366-2000. The official website for NorthWest Healthcare Properties Real Estate Investment Trust is www.nwhreit.com. Learn More about contacing NorthWest Healthcare Properties Real Estate Investment Trust investor relations.